MedPath

Social Determinants of Health in Hepatobiliary Cancer Patients

Recruiting
Conditions
Malignant Hepatobiliary Neoplasm
Registration Number
NCT06053333
Lead Sponsor
Mayo Clinic
Brief Summary

This study evaluates barriers to receiving care and risks associated with developing cancer among patients diagnosed with hepatobiliary cancer.

Detailed Description

PRIMARY OBJECTIVE:

I. To characterize the social determinants of health - and specifically travel-limiting access to cancer care but also other issues, such as trouble in finding childcare, joblessness, and limited education - among SEA Americans with hepatobiliary cancers, exposure risk including aflatoxin and viral hepatitis among other exposures.

OUTLINE: This is an observational study.

Patients complete a questionnaire, undergo blood, urine, and buccal swab sample collection and have their medical records reviewed on study. Patients also undergo collection of clinically archived tissue samples on study.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
1000
Inclusion Criteria
  • Patients 18+ year of age with hepatobiliary cancers
Exclusion Criteria
  • Patients under 18 years of age

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Percentage of patients reporting transportation barriers that affect medical careBaseline; up to 2 years

Estimated using Social Determinants of Health Screening Tool designed by the American Academy of Family Medicine, by the proportion of patients who respond "yes" to the question, "Do you put off or neglect going to the doctor because of distance or transportation?".

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Mayo Clinic in Rochester

🇺🇸

Rochester, Minnesota, United States

Mayo Clinic in Rochester
🇺🇸Rochester, Minnesota, United States
Clinical Trials Referral Office
Contact
855-776-0015
mayocliniccancerstudies@mayo.edu
Nguyen H. Tran, M.D.
Contact

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.